Form 4: Kindly MD Director Granted 112,781 Restricted Stock Units

Kindly MD, Inc. Director Gregory Elias Xethalis was granted 112,781 Restricted Stock Units (RSUs) as part of his compensation.

Summary

• Director Gregory Elias Xethalis acquired 112,781 shares of Kindly MD, Inc. common stock on September 22, 2025.
• The acquisition was in the form of Restricted Stock Units (RSUs).
• These RSUs vest on August 15, 2026, contingent upon Mr. Xethalis's continued service on the board of directors through the vesting date.
• The transaction price for the RSUs was $0 per share.

Sentiment

Score: 6

Explanation: The RSU grant is a standard compensation event, generally viewed as positive for aligning director and shareholder interests, but it does not represent a significant new development or financial performance indicator.

Positives

• The RSU grant aligns the director's long-term interests with those of the shareholders.
• Incentivizes continued service and commitment from a key board member.

Negatives

• The director does not receive immediate liquidity from this grant.
• Vesting is conditional, meaning the shares could be forfeited if service is terminated prematurely.

Risks

• Risk of forfeiture of the 112,781 Restricted Stock Units if the reporting person's service on the board of directors ceases before the August 15, 2026 vesting date.

Future Outlook

The vesting schedule for the Restricted Stock Units indicates an expectation of continued service from Director Gregory Elias Xethalis on the board of directors until at least August 15, 2026.

Industry Context

The grant of Restricted Stock Units is a common form of equity-based compensation for directors and executives in publicly traded companies, designed to align their interests with long-term shareholder value and encourage retention.

Comparison to Industry Standards

• Equity compensation through Restricted Stock Units (RSUs) is a standard practice across various industries for incentivizing directors and executives, comparable to practices at companies like Pfizer (PFE) or Johnson & Johnson (JNJ) which frequently use RSUs as part of their executive compensation packages.
• The vesting schedule tied to continued service is typical for such grants, ensuring commitment over a specified period.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with long-term shareholder value, potentially leading to more focused decision-making.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The Restricted Stock Units will vest on August 15, 2026, provided Director Gregory Elias Xethalis continues his service on the board.

Key Dates

Keywords

Kindly MD, NAKA, Restricted Stock Units, RSU, Director Compensation, Insider Ownership, Equity Grant, Beneficial Ownership